HiberCell, Inc. has acquired the Imprime PGG program from Biothera Pharmaceuticals, Inc.
This website will deactivate on August 31. To learn more visit HiberCell.com

Tag: Management

Tamas Mir Named Senior Vice President, Finance; CFO Andrew D. C. LaFrence Resigns to Pursue New Opportunity

EAGAN, MN — August 6, 2019 — Biothera Pharmaceuticals, Inc. today announced the appointment of Tamas Mir as Senior Vice President, Finance with responsibility for all finance functions, Human Resources and Information Technology.  Mr. Mir joined Biothera in 2012 as Corporate Controller and was promoted the following year to Vice President, Finance.  Mr. Mir replaces Andrew D. C. LaFrence, who has left Biothera for a...

Read More

Biothera Pharmaceuticals Announces Management Changes

EAGAN, MN — December 13, 2018 — Biothera Pharmaceuticals, Inc. announced today that Chief Executive Officer Barry Labinger has resigned to pursue another opportunity, effectively immediately.  Biothera Holding Corp. Chairman Richard Mueller has been appointed acting CEO.  Jeremy Graff, Ph.D., has been named President in addition to his position as Chief Scientific Officer.  Dr. Graff will have responsibility for Research, Clinical Operations and Manufacturing.  Since...

Read More

Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer

EAGAN, MN — May 16, 2018 — Biothera Pharmaceuticals, Inc., announced the appointment of Andrew D.C. LaFrence, CPA as Senior Vice President and Chief Financial Officer, effective May 29.  Biothera Pharmaceuticals is a clinical stage immuno-oncology company developing a novel immunotherapy in combination with immune checkpoint inhibitors for multiple types of cancer. Mr. LaFrence has 34 years of accounting and finance experience, including executive management...

Read More